(Q57275157)

English

The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016,

scientific article published in September 2017

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, (English)

0 references

molecular medicine

0 references

infectious disease

0 references

typhoid vaccine

1 reference

based on heuristic

inferred from title

3

object named as

Buddha Basnyat

0 references

23

object named as

Firdausi Qadri

0 references

object named as

Malick Gibani

2

0 references

Thomas C. Darton

object named as

Thomas C. Darton

6

0 references

Karen L Kotloff

14

object named as

Karen L. Kotloff

0 references

Melita A. Gordon

11

object named as

Melita A. Gordon

0 references

Myron M. Levine

15

object named as

Myron M. Levine

0 references

Kathleen Neuzil

20

object named as

Kathleen Neuzil

0 references

5

object named as

John Clemens

0 references

7

object named as

Kashmira Date

0 references

Bradford D Gessner

10

object named as

Bradford D. Gessner

0 references

Joachim Hombach

13

object named as

Joachim Hombach

0 references

8

object named as

Gordon Dougan

0 references

16

object named as

Stephen P. Luby

0 references

Andrew J. Pollard

22

object named as

Andrew J. Pollard

0 references

Virginia E. Pitzer

21

object named as

Virginia E. Pitzer

0 references

Robert Heyderman

12

object named as

Robert S. Heyderman

0 references

author name string

James E. Meiring

1

0 references

Adwoa D. Bentsi-Enchill

4

0 references

Denise Garrett

9

0 references

Vadrevu Krishna Mohan

17

0 references

Anthony A. Marfin

18

0 references

Kim Mulholland

19

0 references

David Salisbury

24

0 references

Anita Zaidi

25

0 references

language of work or name

0 references

publication date

September 2017

0 references

number of pages

8

1 reference

based on heuristic

inferred from page(s)

0 references

35

0 references

38

0 references

5081-5088

0 references

Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

The burden of typhoid fever in low- and middle-income countries: A meta-regression approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

The Role of Public Health Improvements in Health Advances: The Twentieth-Century United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Challenges and Opportunities for Typhoid Fever Control: A Call for Coordinated Action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

What proportion of Salmonella Typhi cases are detected by blood culture? A systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Global trends in typhoid and paratyphoid Fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

A study of typhoid fever in five Asian countries: disease burden and implications for controls

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Bacteremic typhoid fever in children in an urban slum, Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Differential epidemiology of Salmonella Typhi and Paratyphi A in Kathmandu, Nepal: a matched case control investigation in a highly endemic enteric fever setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Variations of Invasive Salmonella Infections by Population Size in Asante Akim North Municipal, Ghana

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Development of Vi conjugate - a new generation of typhoid vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

The use of typhoid vaccines in Asia: the DOMI experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Typhoid fever in Fiji: a reversible plague?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Etiology of Severe Febrile Illness in Low- and Middle-Income Countries: A Systematic Review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Case fatality rate and length of hospital stay among patients with typhoid intestinal perforation in developing countries: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Use of vaccines as probes to define disease burden

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.08.001

7 January 2021

Identifiers

10.1016/J.VACCINE.2017.08.001

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57275157&oldid=1833590170"